No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Persistent chemotherapy-induced alopecia was more severe with the use of taxanes in breast cancer survivors

byKathleen Lau

October 7, 2021

in StudyGraphics

RELATED REPORTS

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

AstraZeneca moves to own multimodal oncology AI with Modella

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

#VisualAbstract: Dose-escalated intensity-modulated radiotherapy does not improve survival for patients with laryngeal or hypopharyngeal cancers

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Testosterone replacement in male cancer survivors helps improve body composition

Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

Active search for pulmonary embolism does not change outcomes in patients with chronic obstructive pulmonary disease exacerbation

No obesity paradox found between BMI, stroke, and death

Less physical activity and more screen time is associated with poorer mental health in children and adolescents

Why Is Everyone Reading The Decameron Right Now?

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result